Lahore: Highnoon Laboratories Limited has released its financial results for the third quarter ended September 30, 2026, revealing a notable increase in non-current assets compared to the previous year. The announcement, made on October 27, 2026, illustrates a comprehensive picture of the company's financial health.
The unconsolidated condensed interim statement of financial position highlights a significant upsurge in non-current assets, which increased to 5.03 billion rupees from 4.60 billion rupees as of December 31, 2025. This growth is largely attributed to the rise in property, plant, and equipment valuations, which jumped to 4.05 billion rupees from 3.72 billion rupees. There was also an increase in long-term deposits, which rose to 135.46 million rupees from 81.59 million rupees.
Conversely, current assets saw a slight decline to 13.44 billion rupees from 13.81 billion rupees at the end of last year, primarily due to a decrease in short-term investments, which fell to 1.99 billion rupees from 3.06 billion rupees. Trade receivables and cash and bank balances showed a minor move, with trade receivables decreasing marginally to 4.19 billion rupees from 4.21 billion rupees, while cash and bank balances increased moderately to 843.00 million rupees from 468.80 million rupees.
The total assets of Highnoon Laboratories Limited increased marginally, registering a minor move from 18.41 billion rupees to 18.46 billion rupees. The company's equity and liabilities remained stable, with the share capital and reserves slightly decreasing to 13.14 billion rupees from 13.17 billion rupees.
The financial results also unveiled a moderate move in revenue from contracts with customers for the nine months ending September 30, 2026, which stood at 19.32 billion rupees, up from 18.61 billion rupees during the same period in 2025. Despite an increase in gross profit to 10.76 billion rupees from 10.24 billion rupees, the profit after tax for the period showed a minor move, slightly decreasing to 2.62 billion rupees from 2.63 billion rupees in the prior year.
According to information available from the Pakistan Stock Exchange (PSX), Highnoon Laboratories Limited's earnings per share for the nine months ended September 30, 2026, showed a minor move, standing at 4.947 rupees compared to 4.961 rupees for the same period in 2025.
The designated market category for Highnoon Laboratories Limited remains unchanged, as the company continues to navigate the challenges and opportunities present in its industry, maintaining a focus on strategic growth and operational efficiency.